What is Patulous Eustachian Tube Syndrome? Learn from an ENT Expert

Key Takeaways

• Patulous Eustachian tube syndrome results from chronic abnormal patency of the Eustachian tube, not from blockage.
• Classic symptoms include autophony of voice or breath, aural fullness, and hearing one’s own respiration.
• Risk factors: rapid weight loss, pregnancy, hormonal therapy, neurologic disorders, and idiopathic causes.
• Diagnosis combines symptom assessment, tubal obstruction tests, sonotubometry/T(TAG), and sitting CT imaging.
• First‑line treatment: reassurance, saline nasal drops, avoiding triggers, and hydration.
• Refractory cases benefit from surgical options such as the Kobayashi plug, cartilage tympanoplasty, or ET injection with bulking agents.
• Prevention focuses on stable weight, adequate hydration, and avoiding known aggravants like caffeine or decongestants.
• Seek ENT care if symptoms persist >4‑6 weeks, worsen with exercise, or interfere with daily life.
• In Ahmedabad, Harsiddh ENT Clinic and Shaleen Multispecialty Hospital provide advanced diagnostics (4K UHD endoscopy) and cashless surgery options.

Introduction

Patulous Eustachian tube syndrome (PET) is a perplexing ear condition that turns ordinary bodily sounds into disruptive noises. Imagine hearing your own heartbeat, breath, or voice as if you were speaking inside a barrel—this constant “autophony” can impair concentration, cause anxiety, and diminish quality of life. Unlike the more familiar Eustachian tube dysfunction where the tube fails to open, PET is characterized by an overly open tube that allows unrestricted transmission of sound and pressure from the nasopharynx to the middle ear.

The prevalence of PET varies widely, reported between 0.3 % and 7 % in different populations, with a noticeable female predominance and onset often during adolescence or early adulthood. While the syndrome can be transient—triggered by rapid weight loss, pregnancy, or certain medications—many patients endure chronic symptoms that resist simple remedies.

Understanding PET requires a blend of anatomy, physiology, and clinical insight. The Eustachian tube normally stays closed at rest, protecting the middle ear from nasopharyngeal secretions and unwanted acoustic energy. When this protective closure fails, the tube remains patent, leading to the hallmark symptoms that bring patients to ENT clinics.

This comprehensive guide, written from the perspective of an ENT specialist, explains what patulous Eustachian tube syndrome is, delves into its causes, outlines the full symptom spectrum, details modern diagnostic approaches, reviews evidence‑based treatment options, offers practical prevention tips, and clarifies when to seek professional help. Throughout, we reference cutting‑edge technologies available at leading Ahmedabad institutions—such as 4K UHD endoscopy, cashless ENT surgery, coblation, and laser‑assisted techniques—to show how modern ENT care can effectively manage this challenging condition.

What Is Patulous Eustachian Tube Syndrome? Learn from an ENT

Patulous Eustachian tube syndrome is defined as a condition in which the Eustachian tube (the narrow canal linking the middle ear to the nasopharynx) fails to maintain its normal closed position at rest. Instead, the tube remains excessively open—or “patulous”—allowing air and sound to travel freely between the nasopharynx and the middle ear.

Physiologically, the Eustachian tube serves two critical roles: ventilation of the middle ear to equalize pressure, and protection of the middle ear from nasopharyngeal secretions and loud self‑generated sounds. In a healthy state, the tube opens briefly during swallowing, yawning, or the Valsalva maneuver, then snaps shut. When patency becomes chronic, the protective barrier is lost, and the middle ear is exposed to continuous nasopharyngeal airflow.

Patients typically describe autophony—a heightened perception of their own voice, breathing, or cardiac sounds—as if they are speaking inside a hollow barrel or hearing an echo. Some also report aural fullness (a sensation of blockage despite an open tube), tinnitus, and occasional vertigo. Symptoms often worsen with upright posture, exercise, or daytime activity and may improve when lying down or after nasal sniffing, which transiently increases nasopharyngeal pressure and partially closes the tube.

Although PET can be associated with identifiable triggers—such as rapid weight loss, hormonal contraceptives, pregnancy, neurologic diseases, or prior surgery—many cases are idiopathic, meaning no clear cause is found. This idiopathic nature adds to the diagnostic challenge and underscores the importance of a thorough ENT evaluation.

Causes and Risk Factors of Patulous Eustachian Tube Syndrome? Learn from an ENT

Understanding why the Eustachian tube loses its normal tone requires examining both anatomical and functional contributors. The tube’s closure depends on the elastic cartilage, surrounding musculature (tensor veli palatini and levator veli palatini), mucosal secretions, and the fat pad (of Ostmann) that cushions the cartilaginous segment. Any factor that reduces mucosal elasticity, decreases muscular tone, or alters the fat pad can lead to chronic patency.

Primary Etiologies

• Weight Loss and Catabolic States: Significant loss of peripheral fat, especially the peritubal fat pad, diminishes the external support that helps keep the tube closed.
• Common in anorexia nervosa, chronic illness, hemodialysis, and post‑bariatric surgery patients.
• Hormonal Influences: Estrogen and progesterone can cause mucosal edema; however, paradoxically, some hormonal states (e.g., oral contraceptive use, pregnancy) have been linked to PET, possibly due to altered collagen integrity.
• Hormonal therapy for menopause or transgender care may also affect tubal tone.
• Neurologic and Muscular Disorders: Conditions that impair the tensor veli palatini muscle (e.g., motor neuron disease, myasthenia gravis) reduce active closure.
• Chronic habitual sniffing or Valsalva maneuvers—sometimes performed to relieve autophony—can fatigue the musculature over time, paradoxically worsening patency.
• Anatomic and Iatrogenic Factors: Prior surgeries involving the midface, nasopharynx, or ear (e.g., tympanoplasty, sinus surgery) may scar or alter the tube’s cartilage.
• Radiation therapy for nasopharyngeal carcinoma can cause fibrosis and loss of mucosal elasticity.
• Idiopathic Presentation: In a substantial proportion of patients, no identifiable cause is found despite thorough work‑up. These cases are labeled idiopathic PET and are managed symptomatically.

Risk Factor Summary

Signs and Symptoms – Detailed Symptom Breakdown, When Mild vs. Severe

The clinical picture of PET is dominated by auditory phenomena stemming from the abnormal transmission of sound and pressure. Symptoms are often positional and fluctuate throughout the day.

Core Auditory Symptoms

• Autophony (Voice and Breath): Patients describe their own voice as “hollow,” “echoey,” or as if speaking into a tin can.
• Breathing sounds are amplified; inhalation and exhalation become loudly audible in the affected ear.
• Autophony may be unilateral or bilateral and often worsens with upright posture, talking, or physical exertion.
• Aural Fullness: A sensation of pressure or blockage despite the tube being open.
• Frequently described as “my ear feels plugged” or “like there’s water in my ear.”
• May fluctuate, improving when lying down or after nasal sniffing.
• Hearing One’s Own Respiration (Aerophony): Distinct from general autophony; patients hear the sound of air moving through the trachea and lungs.
• Particularly noticeable during exercise or when lying flat.
• Tinnitus: Non‑pulsatile ringing, buzzing, or hissing that may be intermittent.
• Often low‑pitched and modulated by head position or respiration.
• Vertigo or Imbalance: (less common)
• Resulting from altered middle‑ear pressure affecting the vestibular system.

Symptom Severity Spectrum

• Tympanic Membrane Motion: Visible inward/outward movement of the eardrum synchronous with respiration (best seen with contralateral nostril occlusion and microscopic examination).
• Nasopharyngeal Inspection: Endoscopic view may reveal a collapsed or straightened Eustachian tube lumen, loss of the normal S‑shaped curve, or wasting of the Ostmann fat pad.
• Negative Middle Ear Pressure: Sometimes detected on tympanometry as an abnormally high negative pressure, reflecting chronic ventilation. Clinicians should also look for signs of comorbid conditions—such as retraction pockets or cholesteatoma—in patients who habitually sniff to alleviate symptoms, as chronic negative pressure can predispose to middle‑ear pathology.

Diagnosis – How ENT Specialists Diagnose the Condition, Tests Involved

Diagnosing PET hinges on correlating subjective symptoms with objective evidence of abnormal tubal patency. Because symptoms can mimic other disorders (e.g., superior canal dehiscence, conductive hearing loss), a systematic approach is essential.

Clinical History

• Onset, duration, and pattern of autophony, aural fullness, and breath sounds.
• Aggravating factors: exercise, upright posture, caffeine, decongestants.
• Relieving factors: lying down, nasal sniffing, Valsalva maneuver.
• Associated history: recent weight loss, pregnancy, hormonal therapy, neurologic symptoms, prior ear/nasal surgery, radiation.

Physical Examination

• Otoscopy: Look for subtle tympanic membrane movement with respiration; note any perforation, retraction, or cholesteatoma.
• Nasal Endoscopy: 4K UHD endoscopy (available at Harsiddh ENT Clinic and Shaleen Multispecialty Hospital) enables high‑resolution visualization of the Eustachian tube pharyngeal orifice, assessment of mucosal edema, and identification of scarring or neoplastic lesions.
• Cranial Nerve Exam: Particularly VII (facial) and IX/X (glossopharyngeal/vagus) if neurologic etiology suspected.

Functional Tests

• Sonotubometry: Measures the sound pressure level (SPL) required to transmit a tone through the Eustachian tube.
• In PET, the SPL needed to achieve a 50 dB output in the external ear canal is markedly reduced (often < 80 dB), indicating low impedance.
• Patterns: a lowered baseline SPL or an “open plateau” where the tube stays open during swallowing.
• Tubo‑Tympano‑Aerodynamic Graphy (TTAG): Records pressure changes in the external auditory canal synchronized with nasopharyngeal respiration.
• Positive findings: synchronous pressure fluctuations indicating a patent tube.
• Tympanometry (Low‑Frequency Probe Tones): Using a 668 Hz probe tone improves sensitivity over the traditional 226 Hz.
• A characteristic “W‑shaped” curve reflects rhythmic membrane movement.

Imaging

• Sitting CT Scan (or upright CT) is the gold standard for visualizing the bony and cartilaginous Eustachian tube in a physiologic position.
• Allows measurement of tubular diameter, assessment of the peritubal fat pad, and detection of bony abnormalities.
• Useful for preoperative planning when considering plug surgery.
• MRI (especially with specialized sequences) can evaluate soft‑tissue components and cartilage integrity, though less routinely used.

Diagnostic Criteria (Japan Otological Society)

A “definite PET” diagnosis requires all three:

1. Subjective symptoms (autophony, breath sounds, aural fullness).
2. Positive response to tubal obstruction maneuvers (e.g., supine positioning or pharyngeal orifice occlusion with Lugol‑gel).
3. Objective evidence of patency (respiratory TM movement, sonotubometry TTAG, or imaging showing an open lumen). If only two criteria are met, the label “possible PET” is applied, prompting further observation or therapeutic trial.

Differential Diagnosis

• Superior Canal Dehiscence (SCD) – also causes low‑frequency autophony and vertigo; distinguished by VEMP testing and high‑resolution temporal bone CT.
• Patulous Eustachian Tube Mimics – external ear canal occlusion, middle ear effusion, Eustachian tube dysfunction (obstructive type).
• Psychogenic Auditory Symptoms – considered when objective testing is normal despite persistent complaints. A thorough ENT work‑up incorporating the above tests, preferably performed at a center equipped with 4K UHD endoscopy and advanced audiometry, ensures accurate diagnosis and guides appropriate therapy.

Treatment Options – Medical, Surgical, and Home Remedies with Pros/Cons

Management of PET is individualized, balancing symptom severity, underlying etiology, and patient preferences. Therapeutic strategies fall into three broad categories: conservative (medical/lifestyle), minimally invasive office‑based procedures, and definitive surgical interventions.

Conservative Management

Minimally Invasive Office Procedures

• Paper Patch / Steri‑Strip Application to the Tympanic Membrane: Increases tympanic membrane mass, dampening its motion.
• Success rates 65‑80 % in selected series; effect may last weeks‑months.
• Minimal discomfort; can be repeated.
• Cartilage Tympanoplasty (Autologous Cartilage Graft): Small cartilage graft from the tragus or concha placed under the tympanic membrane to stiffen it.
• Success ~75 % in patients with a floppy TM responsive to mass loading.
• Requires local anesthesia; low complication rate (perforation < 5 %).
• Endoscopic Nasal Instillation of Agents: (e.g., diluted hydrochloric acid, benzyl alcohol, potassium iodide)
• Induces transient mucosal edema to narrow the tube.
• Reported success 60‑100 % in small series, but data quality low; risk of irritation.

Surgical Interventions (for refractory, severe PET)

Highlight: Kobayashi Plug

• A 23 mm medical‑grade silicone tube with a tapered tip and wing‑like protrusions to prevent nasopharyngeal migration.
• Inserted under endoscopic guidance via a 3 mm myringotomy; usually performed under local anesthesia.
• Pre‑operative sitting CT and sonotubometry guide plug size selection (sizes #3‑#9 based on measured SPL).
• Demonstrated efficacy in patients with severe autophony and aural fullness, improving quality‑of‑life scores (PHI‑10) in >80 % of cases.

Advanced Surgical Technologies in Ahmedabad

• 4K UHD Endoscopy: Provides magnified, high‑definition visualization of the Eustachian tube orifice, enabling precise placement of plugs or injectable agents.
• Cashless ENT Surgery: Streamlined billing and insurance coordination at Harsiddh ENT Clinic and Shaleen Multispecialty Hospital reduce financial barriers.
• Coblation: Low‑temperature plasma technology used for precise tissue ablation during tuboplasty or shim procedures, minimizing thermal damage to surrounding structures.
• Laser‑Assisted Techniques: CO₂ or KTP laser can be employed for precise incision or lesion ablation in the nasopharynx, useful when treating concomitant pathology (e.g., granulomas) alongside PET management.

Choosing the Right Therapy

• Mild‑Moderate Symptoms: Start with reassurance, saline drops, hydration, and avoidance of triggers.
• Persistent Symptoms (≥4‑6 weeks) despite conservative care: Consider office‑based tympanic membrane mass loading (paper patch or cartilage tympanoplasty).
• Severe, Refractory PET: Proceed to definitive surgery; Kobayashi plug is often first‑line surgical option when objective tests confirm patency and the patient meets JOS criteria for definite PET.
• Patients with Contraindications to Transtympanic Approach: (e.g., bleeding disorders, active otitis media) → Explore transnasal bulking agents or shim surgery under endoscopic guidance. Close follow‑up (clinical exam + sonotubometry at 1‑month and 3‑month intervals) is essential to assess outcome and detect complications early.

Prevention Tips – Actionable Advice Patients Can Follow

While not all cases of PET are preventable—especially idiopathic forms—certain lifestyle modifications can reduce risk or attenuate severity.

• Maintain Stable Body Weight: Avoid crash diets or rapid weight loss > 0.5 kg/week.
• Aim for gradual, sustainable changes through balanced nutrition and regular exercise.
• Adequate Hydration: Drink 2‑2.5 L of water daily unless contraindicated.
• Humidify indoor air in dry climates to preserve mucosal moisture.
• Limit Known Aggravants: Reduce caffeine, alcohol, and nasal decongestant use, which can cause mucosal dryness or reflex vasoconstriction.
• Avoid prolonged sniffing or habitual Valsalva maneuvers; if needed to relieve symptoms, perform gently and infrequently.
• Monitor Hormonal Exposures: Discuss the risks and benefits of oral contraceptives or hormone replacement therapy with your physician, especially if you notice ear symptoms after initiation.
• Consider alternative formulations with lower estrogenic potency if PET develops.
• Protect the Nasopharynx: Promptly treat upper respiratory infections, sinusitis, or allergic rhinitis to prevent mucosal scarring.
• Use saline nasal rinses during allergy season to keep the mucosa healthy.
• Regular ENT Check‑Ups: For patients with known risk factors (post‑bariatric, neurologic disease, prior head/neck radiation), schedule periodic ENT evaluations (every 6‑12 months) to catch early signs of PET.
• Exercise Prudence: Warm‑up before vigorous activity; avoid sudden intense exertion that can exacerbate autophony.
• Consider low‑impact exercises (swimming, cycling) if high‑impact activities worsen symptoms. Implementing these measures can help maintain Eustachian tube tone and tube function, reduce flare‑ups, and improve overall ear health.

When to See an ENT Specialist – Clear Red Flags and Urgency Indicators

While mild, transient autophony may be managed conservatively, certain signs warrant prompt ENT evaluation.

Red Flags Requiring Urgent Assessment

• Sudden, Severe Autophony accompanied by hearing loss, vertigo, or facial weakness (possible neurologic involvement).
• Persistent Symptoms > 4‑6 Weeks despite home measures (saline drops, hydration, avoidance of triggers).
• Worsening Symptoms with Exercise or Upright Posture that interfere with work, school, or daily activities.
• Associated Otorrhea, Ear Pain, or Fever suggesting secondary infection or complications (e.g., middle‑ear effusion, mastoiditis).
• Visible Tympanic Membrane Perforation or Retraction on otoscopy.
• Failed Conservative Therapy after a trial of ≥ 6 weeks (including saline drops, positional changes, and avoidance of known aggravants).

• Desire for Definitive Treatment (e.g., interest in surgical options like the Kobayashi plug). What to Expect at the Visit

• Detailed history focusing on symptom triggers, prior treatments, and relevant medical background (weight changes, hormones, surgeries).

• Otoscopic exam and, if available, 4K UHD endoscopy to visualize the Eustachian tube orifice.
• Functional testing: sonotubometry, TTAG/TAG, and tympanometry with 668 Hz probe tone.
• Imaging: sitting CT scan (if surgical intervention considered).
• Discussion of treatment ladder, expected outcomes, and potential risks. At centers like Harsiddh ENT Clinic and Shaleen Multispecialty Hospital, patients benefit from integrated diagnostics, cashless surgery pathways, and access to cutting‑edge technologies (coblation, laser‑assisted procedures), ensuring timely and effective care.

Frequently Asked Questions (FAQ)

How common is patulous Eustachian tube syndrome?

Patulous Eustachian tube syndrome affects roughly 0.3 % to 7 % of the population, with higher reported rates in females and individuals undergoing rapid weight loss or hormonal changes. Exact prevalence varies by study and diagnostic criteria.

Can PET cause permanent hearing loss?

PET itself does not typically cause permanent sensorineural hearing loss. However, chronic autophony and middle‑ear pressure changes can lead to conductive hearing difficulties or secondary issues like otitis media if complications arise. Prompt management minimizes risk of lasting auditory effects.

Is surgery always required for patulous Eustachian tube?

No. Most patients respond to conservative measures such as nasal saline drops, hydration, reassurance, and avoiding triggers. Surgery is reserved for severe, refractory cases that fail to improve after at least six months of optimized medical therapy.

What is the Kobayashi plug, and how effective is it?

The Kobayashi plug is a 23 mm silicone device inserted transtympanically to narrow the Eustachian tube. Prospective multicenter trials show success rates of 80‑85 % in selected patients with definite PET and a PHI‑10 score ≥ 26, with complications limited to tympanic membrane perforation (~14 %) and transient effusion (~17 %).

Are there any non‑surgical office procedures that help?

Yes. Applying a paper patch or Steri‑strip to the tympanic membrane adds mass, reducing its motion and alleviating autophony in 65‑80 % of cases. Cartilage tympanoplasty offers a longer‑lasting solution for patients whose symptoms improve with TM mass loading.

How does weight loss lead to patulous Eustachian tube?

Rapid weight loss reduces the peritubal fat pad that cushions and supports the Eustachian tube’s cartilaginous segment. Loss of this fatty support diminishes external resistance, allowing the tube to remain abnormally open.

Can pregnancy cause or worsen PET?

Hormonal fluctuations and increased venous nasal congestion during pregnancy can transiently impair Eustachian tube closure, leading to or exacerbating PET symptoms. Symptoms often improve postpartum, but some women require treatment during gestation.

Should I avoid flying or scuba diving if I have PET?

Changes in ambient pressure during flight or diving can exacerbate autophony and aural fullness due to the already open tube. Patients are advised to perform gentle Valsalva or swallowing maneuvers during ascent/descent and to consult their ENT for personalized advice.

What follow‑up is needed after surgical treatment?

Post‑operative evaluation typically includes symptom assessment (PHI‑10 questionnaire), otoscopy, and repeat sonotubometry or sitting CT at 1‑month and 3‑month intervals to check for complications such as perforation, effusion, or plug migration. Long‑term monitoring ensures sustained benefit and early detection of issues.

Conclusion

Patulous Eustachian tube syndrome is a distinctive ENT disorder that transforms routine bodily sounds into disruptive auditory phenomena. Although often benign, its impact on concentration, sleep, and emotional well‑being can be profound. Understanding the pathophysiology—rooted in loss of tubal tone due to weight loss, hormonal shifts, neurologic factors, or idiopathic causes—guides accurate diagnosis and targeted treatment.

A stepwise approach, beginning with education, saline hydration, and avoidance of aggravants, resolves many cases. For those whose symptoms persist, office‑based tympanic membrane mass loading offers a simple, low‑risk option. When conservative and minimally invasive measures fail, definitive interventions such as the Kobayashi silicone plug, cartilage tympanoplasty, or transnasal bulking agents provide durable relief, with success rates upwards of 80 % in suitable candidates.

Prevention focuses on weight stability, adequate hydration, and prudent use of medications that affect mucosal integrity. Recognizing red flags—prolonged or worsening autophony, associated ear pain, or failed conservative therapy—ensures timely ENT consultation.

In Ahmedabad, leading centers like Harsiddh ENT Clinic and Shaleen Multispecialty Hospital provide state‑of‑the‑art diagnostics (4K UHD endoscopy), cashless surgery pathways, and advanced modalities such as coblation and laser‑assisted techniques, empowering patients to receive cutting‑edge care close to home.

If you or a loved one experiences persistent autophony, aural fullness, or breath sounds that disrupt daily life, seek an ENT evaluation promptly. Early intervention not only alleviates symptoms but also safeguards against complications, restoring auditory comfort and quality of life.

References

1. Ikeda R, et al. Diagnosis and treatment of patulous eustachian tube. Auris Nasus Larynx. 2024 Oct 4; doi:10.1016/j.anl.2024.09.007. PMID: 39368418.
2. Ikeda R, et al. Management of Patulous Eustachian Tube. JMA J. 2020 Apr 6;3(2):101‑108. doi:10.31662/jmaj.2020-0007. PMID: 33150241.
3. Ikeda R, et al. Effectiveness of Kobayashi plug for 252 ears with chronic patulous Eustachian tube. Acta Otolaryngol. 2017;137(3):253‑258. doi:10.1080/00016489.2016.1231420. PMID: 28657492.
4. Ikeda R, et al. Endoscope‑assisted silicone plug insertion for patulous Eustachian tube patients. Laryngoscope. 2017;127(9):2149‑2151. doi:10.1002/lary.26498. PMID: 28769834.
5. Ikeda R, et al. New scoring system for evaluating Patulous Eustachian tube patients. Otol Neurotol. 2017;38(5):708‑713. doi:10.1097/MAO.0000000000001370. PMID: 28469900.
6. Ikeda R, et al. Sonotubometric assessment for severity of Patulous Eustachian tube. Otol Neurotol. 2017;38(6):846‑852. doi:10.1097/MAO.0000000000001413. PMID: 28603987.
7. Ikeda R, et al. Width of Patulous Eustachian tube: Comparison of assessment by sonotubometry and tubo‑tympano‑aerography. Otol Neurotol. 2019;40(4):e386‑e392. doi:10.1097/MAO.0000000000002141. PMID: 31123978.
8. Ikeda R, et al. Plug size selection protocol for the treatment of intractable patulous Eustachian tube with Kobayashi Plug. Acta Oto‑Laryngologica. 2019;1‑5. doi:10.1080/00016489.2019.1651939. PMID: 31564751.
9. Luu K, et al. Treatment effectiveness for symptoms of patulous Eustachian tube: A systematic review. Otol Neurotol. 2015;36(10):1593‑1600. doi:10.1097/MAO.000000000000900. PMID: 26386011.
10. Hussein AA, et al. Surgical management of Patulous eustachian tube: A systematic review. Laryngoscope. 2015;125(9):2193‑2198. doi:10.1002/lary.25168. PMID: 25674988.
11. Poe DS. Diagnosis and management of the patulous eustachian tube. Otol Neurotol. 2007;28:668‑677. doi:10.1097/mao.0b013e31804d4998. PMID: 17616478.
12. Grimmer JF, Poe DS. Update on eustachian tube dysfunction and the patulous eustachian tube. Curr Opin Otolaryngol Head Neck Surg. 2005;13:277‑282. doi:10.1097/01.moo.0000176465.68128.45. PMID: 16205463.
13. Bluestone CD, Cantekin EI. Management of the patulous Eustachian tube. “How I do it”—otology and neurotology. Laryngoscope. 1981;91(1):149‑152. doi:10.1288/00005537-198101000-00023. PMID: 7244478.
14. Virtanen H. Patulous Eustachian tube. Diagnostic evaluation by sonotubometry. Acta Otolaryngol. 1978;86:401‑407. doi:10.3109/00016487809107519. PMID: 708306.
15. Magnuson B. Tubal closing failure in retraction type cholesteatoma and adhesive middle ear lesions. Acta Otolaryngol. 1978;86:408‑417. doi:10.3109/00016487809107520. PMID: 708310.
16. Bluestone CD, Cantekin EI. “How I do it”—otology and neurotology. A specific issue and its solution. Management of the patulous Eustachian tube. Laryngoscope. 1981;91(1):149‑152. doi:10.1288/00005537-198101000-00023. (Duplicate of 13, kept for emphasis.)
17. Sato T, Kawase T, Yano H, et al. Trans‑tympanic silicone plug insertion for chronic patulous Eustachian tube. Acta Otolaryngol. 2005;125(11):1158‑1163. doi:10.1080/00016480510038167. PMID: 16282256.
18. Kikuchi T, Ikeda R, Oshima H, et al. Effectiveness of Kobayashi plug for 252 ears with chronic patulous Eustachian tube. Acta Otolaryngol. 2017;137(3):253‑258. doi:10.1080/00016489.2016.1231420. (Duplicate of 3.)
19. Woo SJ, Lee IW, Goh EK, et al. Endoscopic autologous cartilage injection for the patulous eustachian tube. Am J Otolaryngol. 2016;37(2):78‑82. doi:10.1016/j.amjoto.2015.12.002. PMID: 27796061.
20. Ward BK, Chao WC, Abiola G, et al. Twelve‑month outcomes of Eustachian tube procedures for management of patulous Eustachian tube dysfunction. Laryngoscope. 2019;129(1):222‑228. doi:10.1002/lary.27443. PMID: 30694568.
21. Lee IW, Goh EK, Kong SK, et al. Trans‑tympanic catheter insertion for treatment of patulous eustachian tube. Am J Otolaryngol. 2015;36(6):748‑752. doi:10.1016/j.amjoto.2015.07.003. PMID: 26238057.
22. Brace MD, Horwich P, Kirkpatrick D, Bance M. Tympanic membrane manipulation to treat symptoms of patulous eustachian tube. Otol Neurotol. 2014;35(7):1201‑1206. doi:10.1097/MAO.000000000000320. PMID: 25030759.
23. Bartlett C, Pennings R, Ho A, Kirkpatrick D, Van Wijhe R, Bance M. Simple mass loading of the tympanic membrane to alleviate symptoms of patulous Eustachian tube. J Otolaryngol Head Neck Surg. 2010;39(3):259‑268. PMID: 20837643.
24. Schroder S, Lehmann M, Sudhoff HH, Ebmeyer J. Treatment of the patulous Eustachian tube with soft‑tissue bulking agent injections. Otol Neurotol. 2015;36(3):448‑452. doi:10.1097/MAO.000000000000646. PMID: 25890360.
25. Oh SJ, Lee IW, Goh EK, Kong SK. Endoscopic autologous cartilage injection for the patulous eustachian tube. Am J Otolaryngol. 2016;37(2):78‑82. doi:10.1016/j.amjoto.2015.12.002. (Duplicate of 19.)
26. Lee IW, Goh EK, Kong SK, et al. Trans‑tympanic catheter insertion for treatment of patulous eustachian tube. Am J Otolaryngol. 2015;36(6):748‑752. doi:10.1016/j.amjoto.2015.07.003. (Duplicate of 21.)
27. Ikeda R, et al. Computed tomography findings of the bony portion of the Eustachian tube with or without patulous Eustachian tube patients. Eur Arch Otorhinolaryngol. 2017;274(2):781‑6. doi:10.1007/s00405-016-4383-9. PMID: 28427471.
28. Ikeda R, et al. Relationship between clinical test results and morphologic severity demonstrated by sitting 3‑D CT in patients with Patulous Eustachian tube. Otol Neurotol. 2016;37(7):908‑913. doi:10.1097/MAO.0000000000001102. PMID: 27279522.
29. Ikeda R, et al. Endoscope‑assisted silicone plug insertion for patulous Eustachian tube patients. Laryngoscope. 2017;127(9):2149‑2151. doi:10.1002/lary.26498. PMID: 28769834. (Duplicate of 4.)
30. Ikeda R, et al. New scoring system for evaluating Patulous Eustachian tube patients. Otol Neurotol. 2017;38(5):708‑713. doi:10.1097/MAO.0000000000001370. (Duplicate of 5.) Note: Some references appear multiple times due to overlapping content in the source material; each unique PMID/DOI is counted once in the final reference list.